Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing (Record no. 4629)
[ view plain ]
000 -LEADER | |
---|---|
fixed length control field | 01384 a2200337 4500 |
001 - CONTROL NUMBER | |
control field | 1498704166 |
005 - DATE AND TIME OF LATEST TRANSACTION | |
control field | 20250317111607.0 |
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
fixed length control field | 250312042016xx 30 eng |
020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
International Standard Book Number | 9781498704168 |
037 ## - SOURCE OF ACQUISITION | |
Source of stock number/acquisition | Taylor & Francis |
Terms of availability | GBP 48.99 |
Form of issue | BB |
040 ## - CATALOGING SOURCE | |
Original cataloging agency | 01 |
041 ## - LANGUAGE CODE | |
Language code of text/sound track or separate title | eng |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | TDCW |
Source | thema |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | MBNS |
Source | thema |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | PS |
Source | thema |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | PBT |
Source | thema |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | TDCW |
Source | bic |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | MBNS |
Source | bic |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | PS |
Source | bic |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | PBT |
Source | bic |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | MAT029000 |
Source | bisac |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | MED071000 |
Source | bisac |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | MED090000 |
Source | bisac |
072 7# - SUBJECT CATEGORY CODE | |
Subject category code | 615.19 |
Source | bisac |
100 1# - MAIN ENTRY--PERSONAL NAME | |
Personal name | Harry Yang |
245 10 - TITLE STATEMENT | |
Title | Emerging Non-Clinical Biostatistics in Biopharmaceutical Development and Manufacturing |
250 ## - EDITION STATEMENT | |
Edition statement | 1 |
260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
Name of publisher, distributor, etc. | Chapman and Hall/CRC |
Date of publication, distribution, etc. | 20161130 |
300 ## - PHYSICAL DESCRIPTION | |
Extent | 386 p |
520 ## - SUMMARY, ETC. | |
Expansion of summary note | The premise of Quality by Design (QbD) is that the quality of the pharmaceutical product should be based upon a thorough understanding of both the product and the manufacturing process. This state-of-the-art book provides a single source of information on emerging statistical approaches to QbD and risk-based pharmaceutical development. A comprehensive resource, it combines in-depth explanations of advanced statistical methods with real-life case studies that illustrate practical applications of these methods in QbD implementation. |
No items available.